Patients with uncontrolled gout may benefit from a combination of pegloticase and methotrexate therapy, according to a small, retrospective study…
eConsult Communications Reveal the Common Questions from Primary Care Physicians about Rheumatology Care
A recent study reveals the common misconceptions of primary care physicians about rheumatologic care, such as the difference between inflammatory and non-inflammatory arthropathy. Researchers believe such misconceptions can be targeted to improve patients’ timely access to care and diagnosis…
Myositis Autoantibodies: A Comparison of Serotyping Panels
The challenges of diagnosing myositis are numerous, with many tests resulting in false positives and negatives for autoantibody levels. Researchers recently compared a line blot array currently being used in research with the Oklahoma Medical Research Foundation Myositis panel, which is used in clinical testing. They found some patients were positive according to the research test, but negative according to the clinical test…
ACR Publishes Disease Activity and Functional Status Assessment Measure Recommendations for RA
The recommendations include updated disease activity measures and a new set of functional status assessment measures for rheumatoid arthritis.
FDA Approves Amgen’s Infliximab Biosimilar Treatment
(Reuters)—The U.S. Food and Drug Administration on Friday approved Amgen Inc.’s biosimilar copy of Johnson & Johnson’s blockbuster rheumatoid arthritis drug, Remicade (infliximab), according to the regulator’s website. The biosimilar, Avsola (infliximab-axxq), has the same chemical components, dosage form and strength as Remicade and would treat a range of autoimmune disorders. The label for the…
Spotlight on Ethics & Conflicts of Interest: A Conversation with Karen Onel, MD, New Chair of the ACR’s Ethics Committee
Karen Onel, MD, new chair of ACR’s Committee on Ethics & Conflict of Interest, brings a longstanding interest in issues related to ethics and consent.
2019 RheumPAC Matching Campaign Donors Recognized
Contributions from ACR/ARP members and volunteer leaders raised more than $36,000 in November to support rheumatology advocacy efforts.
2019 MIPS Reporting via RISE: Are You Ready?
It’s time to prepare for 2019 MIPS reporting via the Rheumatology Informatics System for Effectiveness (RISE) registry, and the ACR is here to help. To ensure you’re ready to submit your data to the Centers for Medicare & Medicaid Services (CMS), RISE users should take the following steps: Review your data in the dashboard; Make…
Reimbursement Options for Services Without Direct Patient Contact
Beginning in October 2019, two major commercial payers, UnitedHealthcare and Cigna, discontinued payment for consultation services. The CPT codes affected include 99241–99245 and 99251–99255. The payers have instructed providers to instead bill the non-consultative evaluation and management (E/M) codes that best describe the services performed. If the non-face-to-face service goes beyond the usual time a…
Nailfold Videocapillaroscopy Provides a Window into Inflammatory Myopathies
A recent study investigated the possible differences in nailfold videocapillaroscopy in four types of inflammatory myopathies. Researchers observed giant capillaries, disorganization and major capillary loss in dermatomyositis and overlap myositis patients, finding dermatomyositis and overlap myositis imaging was different from that of antisynthetase syndrome and immune-mediated necrotizing myopathy…
- « Previous Page
- 1
- …
- 227
- 228
- 229
- 230
- 231
- …
- 814
- Next Page »